iQure Pharma

Princeton, NJ · Founded 2019 · Privately Held (backing)

Developer of biopharmaceutical therapies designed to address central nervous system disorders by restoring glutamate homeostasis. iQure Pharma is based in Princeton, NJ and was founded in 2019. Its last reported valuation was $21 million in Nov 2025. It has raised $13.1 million across 4 recorded rounds; the latest was a $650,000 seed round in May 2026.

Last reported valuation
$21.0M
Oct 2026
Priced at
—
Total raised
$13.1M
Last round
Seed Round
May 2026

Who backs iQure Pharma?

8 investors
InvestorType
Keiretsu ForumOther
Endless Frontier Labs—
SideCar AngelsAngel
Accelerator Venture Partners—
Mass Medical Angels—
OKG Capital—
Ventura BioMed Investors—
i&i Biotech Fund—
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

iQure Pharma investors

8 investors are on record for iQure Pharma, including Keiretsu Forum, Endless Frontier Labs, SideCar Angels and Accelerator Venture Partners. The seed round in May 2026 drew 1 investor.

Free account
More of iQure Pharma with a free account
  • ·Watch iQure Pharma: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 8 firms already write checks for companies like iQure Pharma. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View